Efficacy, safety, tolerability, and pharmacokinetics of EPI-506 (ralaniten acetate), a novel androgen receptor (AR) N-terminal domain (NTD) inhibitor, in men with metastatic castra... von Chi, Kim N., Vaishampayan, Ulka N., Gordon, Michael S., Smith, David C., Rudsinski, Erin, De Haas-Amatsaleh, Angela, Thapar, Neil, Perabo, Frank, Montgomery, Robert B.

Volltext